Puma Biotech (PBYI) Tops Q3 EPS by 10c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 10.44 -0.1 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.54 | 52 Week High | $82.81 | |||
| Open | $10.56 | 52 Week Low | $19.74 | |||
| Day High | $10.66 | P/E | N/A | |||
| Day Low | $10.36 | EPS | $-2.16 | |||
| Volume | 339,257 | |||||
